Fund Holdings — Velan Capital Investment Management LP

Total Portfolio Value:
$174.55M
Total Bought:
$11.22M
Total Sold:
$26.97M
Net Transaction:
-$15.75M
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Alimera Sciences Inc13,608,53313,608,5330$53.07M$75.66M43.35%+$22.59M
Jasper Therapeutics, Inc.(JSPR)1,471,9041,471,9040$42.10M$32.55M18.65%-$9.55M
Heron Therapeutics, Inc.(HRTX)6,986,7446,986,7440$19.35M$24.45M14.01%+$5.10M
Praxis Precision Medicines, Inc.(PRAX)350,666350,6660$21.40M$14.50M8.31%-$6.89M
Tourmaline Bio Inc319,080319,0800$7.31M$4.10M2.35%-$3.20M
TELA Bio, Inc.(TELA)746,087746,0870$4.23M$3.51M2.01%-$723.7K
Rezolute, Inc.(RZLT)400,000800,000+400,000$1.02M$3.44M1.97%+$2.42M
Skye Bioscience, Inc.(SKYE)0422,142+422,142$0$3.38M1.94%+$3.38M
Optinose Inc3,001,1912,492,830-508,361$4.38M$2.59M1.49%-$1.79M
Context Therapeutics Inc.(CNTX)01,290,323+1,290,323$0$2.59M1.48%+$2.59M
InspireMD, Inc.(NSPR)904,029904,0290$2.14M$2.26M1.29%+$113.2K
Outlook Therapeutics, Inc.(OTLK)500,000247,084-252,916$5.97M$1.82M1.04%-$4.15M
Elevation Oncology Inc497,299597,299+100,000$2.55M$1.61M0.92%-$938.4K
Protara Therapeutics, Inc.(TARA)0480,000+480,000$0$998.4K0.57%+$998.4K
Kiora Pharmaceuticals, Inc.(KPRX)0122,223+122,223$0$513.3K0.29%+$513.3K
X4 Pharmaceuticals, Inc.(XFOR)0659,020+659,020$0$382.2K0.22%+$382.2K
Aslan Pharmaceuticals LtdADS625,000625,0000$384.5K$187.5K0.11%-$197.0K
Adma Biologics Inc1,528,6010-1,528,601$10.09M$0—-$10.09M
Aquestive Therapeutics Inc600,0000-600,000$2.56M$0—-$2.56M
enVVeno Medical Corporation(NVNO)172,2350-172,235$937.0K$0—-$937.0K
Geron Corporation(GERN)500,0000-500,000$1.65M$0—-$1.65M
Inspire Medical Systems, Inc.(INSP)18,0000-18,000$3.87M$0—-$3.87M
Kiora Pharmaceuticals Inc1,100,0000-1,100,000$776.6K$0—-$776.6K
Milestone Pharmaceuticals Inc.(MIST)650,0000-650,000$1.16M$0—-$1.16M
Page 1 of 1
Velan Capital Investment Management LP — 13F Holdings — Q2 2024 | TickerTrail